These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11910261

  • 1. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin.
    Desta Z, Soukhova N, Flockhart DA.
    J Clin Psychopharmacol; 2002 Apr; 22(2):162-8. PubMed ID: 11910261
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.
    von Moltke LL, Greenblatt DJ, Duan SX, Harmatz JS, Wright CE, Shader RI.
    J Clin Psychopharmacol; 1996 Apr; 16(2):104-12. PubMed ID: 8690825
    [Abstract] [Full Text] [Related]

  • 3. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE, Ahern D, Scatina J, Kao J.
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [Abstract] [Full Text] [Related]

  • 4. Identification and characterization of human cytochrome P450 isoforms interacting with pimozide.
    Desta Z, Kerbusch T, Soukhova N, Richard E, Ko JW, Flockhart DA.
    J Pharmacol Exp Ther; 1998 May; 285(2):428-37. PubMed ID: 9580580
    [Abstract] [Full Text] [Related]

  • 5. Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: in vitro studies using human liver microsomes.
    Hemeryck A, De Vriendt C, Belpaire FM.
    J Clin Psychopharmacol; 2000 Aug; 20(4):428-34. PubMed ID: 10917404
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.
    Hemeryck A, De Vriendt C, Belpaire FM.
    Eur J Clin Pharmacol; 1999 Feb; 54(12):947-51. PubMed ID: 10192756
    [Abstract] [Full Text] [Related]

  • 7. The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites.
    Chapron BD, Dinh JC, Toren PC, Gaedigk A, Leeder JS.
    Drug Metab Dispos; 2020 Nov; 48(11):1113-1120. PubMed ID: 32847865
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
    von Moltke LL, Greenblatt DJ, Court MH, Duan SX, Harmatz JS, Shader RI.
    J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
    Daniel WA, Syrek M, Haduch A, Wójcikowski J.
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors.
    Nelson MH, Birnbaum AK, Remmel RP.
    Epilepsy Res; 2001 Apr; 44(1):71-82. PubMed ID: 11255075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
    Casabar RC, Wallace AD, Hodgson E, Rose RL.
    Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P.
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [Abstract] [Full Text] [Related]

  • 19. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
    Crewe HK, Lennard MS, Tucker GT, Woods FR, Haddock RE.
    Br J Clin Pharmacol; 1992 Sep; 34(3):262-5. PubMed ID: 1389951
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.